Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism (API-CAT): a post-hoc analysis of a randomised, non-inferiority trial — Isabelle Mahé (2025) | RDL Network
Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism (API-CAT): a post-hoc analysis of a randomised, non-inferiority trial
Faizan Khan, Tobias Tritschler, Miriam Kimpton, Philip S. Wells, Clive Kearon, Jeffrey I. Weitz, Harry R. Büller, Gary E. Raskob, Walter Ageno, Françis Couturaud, Paolo Prandoni, Gualtiero Palareti, Cristina Legnani, Paul A. Kyrle, Sabine Eichinger, Lisbeth Eischer, Cecilia Becattini, Giancarlo Agnelli, Maria Cristina Vedovati, Geert‐Jan Geersing, Toshihiko Takada, Benilde Cosmi, Drahomir Aujesky, Letizia Marconi, Antonio Palla, Sergio Siragusa, Charlotte Bradbury, Sameer Parpia, Ranjeeta Mallick, Anthonie W.A. Lensing, Martin Gebel, Michael Grosso, Kednapa Thavorn, Brian Hutton, Grégoire Le Gal, Dean Fergusson, Marc Rodger
Maria Cristina Vedovati, Michela Giustozzi, Andrés J. Muñoz Martín, Laurent Bertoletti, Alexander T. Cohen, Frederikus A. Klok, Jean M. Connors, Rupert Bauersachs, Benjamin Brenner, Mauro Campanini, Cecilia Becattini, Giancarlo Agnelli
Rustam Al‐Shahi Salman, Catriona Keerie, Jacqueline Stephen, Steff Lewis, John Norrie, Martin Dennis, David E. Newby, Joanna M. Wardlaw, Professor Gregory Lip, Adrian Parry‐Jones, Phil White, Colin Baigent, Daniel Lasserson, Colin Oliver, Fiach C. O’Mahony, Shannon Amoils, John Bamford, Jane Armitage, Jonathan Emberson, Gabriel Rinkel, Gordon Lowe,
.jpg){kind=small}
Discussion(0)
No comments yet. Be the first to comment.